Thus, AD and NPC represent two distinct diseases sharing some disease‐related molecular pathways, including cholesterol metabolism defects but also involvement of amyloid‐β (Aβ) and tau pathology [13]. The gene discussed is MAPT; the disease is Alzheimer disease.